Filing Details
- Accession Number:
- 0001179110-20-011058
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2020-11-12 17:55:54
- Reporting Period:
- 2020-11-04
- Accepted Time:
- 2020-11-12 17:55:54
- Original Submission Date:
- 2020-11-06
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1551152 | Abbvie Inc. | ABBV | Pharmaceutical Preparations (2834) | 320375147 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1563545 | Azita Saleki-Gerhardt | 1 N. Waukegan Road North Chicago IL 60064 | Evp, Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.01 Par Value | Acquisiton | 2020-11-04 | 4,800 | $24.21 | 118,667 | No | 4 | M | Direct | |
Common Stock, $0.01 Par Value | Disposition | 2020-11-04 | 4,800 | $93.61 | 113,867 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Option (Right to buy) | Disposition | 2020-11-04 | 4,800 | $0.00 | 4,800 | $24.21 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2012-02-18 | 2021-02-17 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock, $0.01 Par Value | 2,027 | Indirect | Profit Sharing Trust |
Common Stock, $0.01 Par Value | 3,873 | Indirect | By Spouse |
Footnotes
- Balance in AbbVie Savings program as of November 10, 2020.
- The reporting person disclaims beneficial ownership of all securities held by her spouse.
- Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.